62
Participants
Start Date
October 30, 2018
Primary Completion Date
August 22, 2019
Study Completion Date
August 22, 2019
Individual Deprescribing Intervention
The pharmacist responsible for the nursing home will perform a medication review (type 3). The results of this review will be discussed with the physician and nurse responsible for this participant, with the goal of creating a personalised deprescribing plan. Once validated by the physician, this plan will be submitted to the participant for approval.
Centre de Pharmacie Communautaire, Lausanne
Anne Niquille
OTHER